SEC Form 4 · accession 0001813798-26-000017
Vaxcyte, Inc. · PCVX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jim Wassil
Officer — CHIEF OPERATING OFFICER
Period of report
Aug 31, 2026
Accepted (ET)
Sep 2, 2026 · 7:58 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001649094
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 31, 2026 | F | 1,273 | $60.74 | D | 156,268 | D | |
| Common Stock | Sep 1, 2026 | M | 2,250 | $5.35 | A | 158,518 | D | |
| Common StockF3 | Sep 1, 2026 | S | 1,537 | $60.886 | D | 156,981 | D | |
| Common StockF4 | Sep 1, 2026 | S | 713 | $61.481 | D | 156,268 | D | |
| Common StockF5 | Sep 1, 2026 | S | 924 | $60.955 | D | 155,344 | D | |
| Common StockF6 | Sep 1, 2026 | S | 303 | $61.424 | D | 155,041 | D | |
| Common StockF1 | Sep 2, 2026 | F | 1,432 | $61.58 | D | 153,609 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F7 | $5.35 | Sep 1, 2026 | M | 2,250 | D | — | Apr 17, 2030 | Common Stock | 2,250 | 66,648 | D |
Explanation of responses
- F1Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
- F2The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025.
- F3The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F6The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F7Stock Option is fully vested and exercisable.